… bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease -
P Garnero - Journal of Clinical Endocrinology & Metabolism, 1993 - Endocrine Soc
... assay (IRMA) in a large sample of healthy controls comprising 173 women and 180
men, 20-88 yr of age, and in patients with metabolic bone disease. ...
… metastatic breast cancer that has progressed after chemotherapy for metastatic disease -
MA Cobleigh, CL Vogel, D Tripathy - feedback, 2005 - biomedcentral.com
... Women eligible for study were those with HER2-overexpressing metastatic breast ... Patients
with untreated brain metastases or bone-only disease were excluded ...
Therapeutic Approaches to Bone Diseases -
GA Rodan, TJ Martin - Science, 2000 - sciencemag.org
... health problem and, although it occurs most commonly in women as a ... to treat these
common conditions, as well as Paget's disease of bone and inflammatory ...
… of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease -
P Garnero - Journal of Clinical Endocrinology & Metabolism, 1994 - Endocrine Soc
... during bone matrix degradation in a sample of healthy adults comprising 146 women
and 60 men, aged 31-89 yr, and in patients with metabolic bone disease. ...
… Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal … -
JY Reginster, HW Minne, OH Sorensen, M Hooper, C … - Osteoporosis International, 2000 - Springer
... therapy for severe postmenopausal osteo- porosis, reducing the incidence of vertebral
fractures and improving bone density in women with established disease. ...
Thyrotoxic Bone Disease in Women: A Potentially Reversible Disorder -
T Diamond, J Vine, R Smart, P Butler - Annals of Internal Medicine, 1994 - annals.highwire.org
... ARTICLE. Thyrotoxic Bone Disease in Women: A Potentially Reversible Disorder. ... The
prevalence of bone fractures in women with thyroid disease (Abstract). ...
… excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease. -
D Uebelhart, E Gineyts, MC Chapuy, PD Delmas - Bone Miner, 1990 - ncbi.nlm.nih.gov
... In women, menopause induced a 2-3-fold increase of HP ... primary hyperparathyroidism
and of patients with active Paget's disease of bone, urinary crosslinks ...
Sunlight ?D? ilemma: risk of skin cancer or bone disease and muscle weakness -
MF Holick - The Lancet, 2001 - Elsevier
... Author a Vitamin D, Skin, and Bone Research Laboratory ... and muscle cramps by 72% of
Arab women, compared with ... cancer and a more aggressive form of the disease. ...
Intravenous Zoledronic Acid in Postmenopausal Women With Low Bone Mineral Density. -
IR Reid, JP Brown, P Burckhardt, Z Horowitz, P … - Obstetrical & Gynecological Survey, 2003 - obgynsurvey.com
... metastatic disease. Although actual fracture data have not been published for
zoledronic acid yet, bone mineral density (BMD) increased in this group of women ...
Intake of trans fatty acids and risk of coronary heart disease among women -
WC Willett, MJ Stampfer, JE Manson, GA Colditz, FE … - Lancet, 1993 - Mass Med Soc
... Citation(s): Willett WC et al. Intake of trans fatty acids and risk of coronary
heart disease among women. Lancet 1993 Mar 6 341 581-585. ...
Source: Google Scholar |